Talecris Biotherapeutics
Canada  |   En Français

  Home About Talecris Canada Our Products Patient Advocacy Media Center  
About Talecris Canada
Talecris Leadership
Talecris Innovations
Contact Talecris Canada

Talecris Leadership



  Larry Stern
Joel Abelson


Larry Stern Larry Stern
Chairman and Chief Executive Officer

Lawrence (Larry) Stern is the Chairman and Chief Executive Officer of Talecris Biotherapeutics. Mr. Stern joined Talecris in April 2005 from Cerberus Capital Management, where he led the evaluation and plan resulting in the contribution of assets of the plasma portion of Bayer Biological Products to Talecris Biotherapeutics.

Mr. Stern joined Bayer Corporation as the President of its Urethanes group in 2000 upon Bayer's $2.5 billion acquisition of Lyondell Chemical's polyol business. Mr. Stern successfully completed a complex, multi-national integration with diverse cultural perspectives and business practices. He led significant restructurings including consolidation of manufacturing plants and R&D facilities, while simultaneously improving operational reliability.

Mr. Stern has a passion for Operational Excellence, and has led dramatic improvements in cost, safety, and environmental performance throughout his career.

Mr. Stern received his B.S. in Chemical Engineering from Cornell University in 1979. He completed his M.S. from the Massachusetts Institute of Technology with a thesis on Fluidized Bed Coal Combustion in 1981.
Joel Abelson Joel Abelson
Senior Vice President and General Manager, Portfolio Management and International Business

As Senior Vice President and General Manager, Portfolio Management and International Business, Mr. Abelson leads Talecris’ Canadian and Intercontinental Operations as well as Operations in Germany and the European Union.  Mr. Abelson has joint responsibility for global portfolio management and plays a pivotal role in developing and implementing strategies to support Talecris’ global expansion.

Mr. Abelson joined Talecris in March 2006 as Vice President, Canada and Intercontinental Commercial Operations with responsibilities for the planning and establishment of Talecris’ Canadian business and Talecris’ commercial operations in all markets outside the US and Europe.

Prior to joining Talecris, Mr. Abelson was with Bayer Healthcare where he held several senior management positions in Canada and the US, including Vice President, Global Strategic Marketing, where he was responsible for marketing strategies across the entire product portfolio.  Prior to that, he was Vice President, Immunology Life Cycle Management, where he was responsible for strategic marketing and preparing the company for the launch of Gamunex® (Immune Globulin Intravenous [Human], 10% Caprylate / Chromatography Purified).

Prior to joining the private sector, Mr. Abelson held various policy and management positions with the Government of Ontario, Canada including service in the Cabinet Office as a Senior Policy Advisor to the Premier’s Policy and Priorities Committee.  He also led the Province’s joint private/public sector health economic development initiative to accelerate the growth of the Province’s pharmaceutical, biotechnology and medical device sectors.

Mr. Abelson has a Bachelor of Arts (Honours) degree from Carleton University in Ottawa, Canada and a Master’s degree in Public Administration from the University of Toronto.

 

 

Print This Page
E-mail This Page
Talecris Products
Learn about Talecris Products available in Canada.
Learn More

 Commitment to Patients
Talecris is committed to providing services and support to patients.
Learn More

Talecris Biotherapeutics
Contact Talecris    Glossary    Site Map
General Conditions of Use    Privacy Statement   
© 2008 Talecris Biotherapeutics